Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.

Won, H K; Kim, K J; Lee, B-W; Kang, E S; Cha, B S; Lee, H C

Won, H K; Kim, K J; Lee, B-W; Kang, E S; Cha, B S; Lee, H C.

Affiliation

Won HK; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Diabet Med ; 29(1): 74-9, 2012 Jan.

Article in En | MEDLINE | ID: mdl-21781151

Subject(s)

Blood Glucose/drug effects; Diabetes Mellitus, Type 2/drug therapy; Glycated Hemoglobin/drug effects; Hypoglycemic Agents/administration & dosage; Insulin/administration & dosage; Serum Albumin/drug effects; Administration, Oral; Analysis of Variance; Blood Glucose/metabolism; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/epidemiology; Female; Follow-Up Studies; Glycated Hemoglobin/metabolism; Glycation End Products, Advanced; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Republic of Korea/epidemiology; Serum Albumin/metabolism; Time Factors; Treatment Outcome; Glycated Serum Albumin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Glycated Hemoglobin / Serum Albumin / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Insulin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google